These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6428460)

  • 1. Apolipoprotein E Bethesda. Isolation and partial characterization of a variant of human apolipoprotein E isolated from very low density lipoproteins.
    Ghiselli G; Gregg RE; Brewer HB
    Biochim Biophys Acta; 1984 Jul; 794(2):333-9. PubMed ID: 6428460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia.
    Havekes L; de Wit E; Leuven JG; Klasen E; Utermann G; Weber W; Beisiegel U
    Hum Genet; 1986 Jun; 73(2):157-63. PubMed ID: 3721502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein EBethesda: a new variant of apolipoprotein E associated with type III hyperlipoproteinemia.
    Gregg RE; Ghiselli G; Brewer HB
    J Clin Endocrinol Metab; 1983 Nov; 57(5):969-74. PubMed ID: 6578216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical familial dysbetalipoproteinemia associated with apolipoprotein phenotype E3/3.
    Havel RJ; Kotite L; Kane JP; Tun P; Bersot T
    J Clin Invest; 1983 Jul; 72(1):379-87. PubMed ID: 6860421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E-1Harrisburg: a new variant of apolipoprotein E dominantly associated with type III hyperlipoproteinemia.
    Mann WA; Gregg RE; Sprecher DL; Brewer HB
    Biochim Biophys Acta; 1989 Oct; 1005(3):239-44. PubMed ID: 2804053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype.
    Rall SC; Weisgraber KH; Innerarity TL; Bersot TP; Mahley RW; Blum CB
    J Clin Invest; 1983 Oct; 72(4):1288-97. PubMed ID: 6313758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type III hyperlipoproteinemia associated with apolipoprotein E deficiency.
    Ghiselli G; Schaefer EJ; Gascon P; Breser HB
    Science; 1981 Dec; 214(4526):1239-41. PubMed ID: 6795720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and epsilon 1/'null' genotype.
    Feussner G; Funke H; Weng W; Assmann G; Lackner KJ; Ziegler R
    Eur J Clin Invest; 1992 Sep; 22(9):599-608. PubMed ID: 1360898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An erroneous apolipoprotein E-3 band in high density lipoprotein fractions.
    Rawlings AV; Deegan T
    J Inherit Metab Dis; 1988; 11 Suppl 2():135-8. PubMed ID: 3141692
    [No Abstract]   [Full Text] [Related]  

  • 10. Distribution of apolipoprotein E isoforms between very low and high density lipoproteins of normal subjects and hyperlipidemic patients with special reference to type III hyperlipidemia.
    Holmquist L
    Acta Med Scand; 1984; 215(2):113-20. PubMed ID: 6702490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1.
    Weisgraber KH; Rall SC; Innerarity TL; Mahley RW; Kuusi T; Ehnholm C
    J Clin Invest; 1984 Apr; 73(4):1024-33. PubMed ID: 6323533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia.
    Ehnholm C; Mahley RW; Chappell DA; Weisgraber KH; Ludwig E; Witztum JL
    Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5566-70. PubMed ID: 6591204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of apolipoprotein B-48 and B-100 very low density lipoproteins from type III hyperlipoproteinemic subjects.
    Milne RW; Weech PK; Blanchette L; Davignon J; Alaupovic P; Marcel YL
    J Clin Invest; 1984 Mar; 73(3):816-23. PubMed ID: 6368590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E2-Dunedin (228 Arg replaced by Cys): an apolipoprotein E2 variant with normal receptor-binding activity.
    Wardell MR; Rall SC; Brennan SO; Nye ER; George PM; Janus ED; Weisgraber KH
    J Lipid Res; 1990 Mar; 31(3):535-43. PubMed ID: 2341812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interference by pro-apolipoprotein A-I in apolipoprotein E phenotyping using chemical precipitation procedures.
    Rawlings AV; Deegan T
    Ann Clin Biochem; 1988 Nov; 25 ( Pt 6)():638-44. PubMed ID: 3254104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo alteration of a mutant human protein using the free thiol cysteamine.
    Gahl WA; Gregg RE; Hoeg JM; Fisher E
    Am J Med Genet; 1985 Feb; 20(2):409-17. PubMed ID: 3976729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparative isoelectric focussing of apolipoproteins C and E from human very low density lipoproteins.
    Marcel YL; Bergseth M; Nestruck AC
    Biochim Biophys Acta; 1979 Apr; 573(1):175-83. PubMed ID: 222332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High receptor binding affinity of lipoproteins in atypical dysbetalipoproteinemia (type III hyperlipoproteinemia).
    Chappell DA
    J Clin Invest; 1989 Dec; 84(6):1906-15. PubMed ID: 2556448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and partial characterization of an arginine-rich apolipoprotein from human plasma very-low-density lipoproteins: apolipoprotein E.
    Utermann G
    Hoppe Seylers Z Physiol Chem; 1975 Jul; 356(7):1113-21. PubMed ID: 172422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein A-II can incorporate into plasma very low density lipoproteins.
    Mao SJ; Kluge K; Squillace SJ
    FEBS Lett; 1981 Sep; 132(2):289-92. PubMed ID: 6795063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.